Endocrinology and Metabolism Research
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section publishes reviews and original peer-reviewed papers of a high scientific level covering all the aspects of endocrinology and metabolism. Papers aiming to uncover molecular and cellular mechanisms in endocrinology and metabolism are welcome. Topics include but are not limited to gene regulation, cell biology, signaling, mutations, growth factors, cytokines, hormone receptors, hormone action and regulation, developmental endocrinology, genetic endocrinology, endocrine diseases (diabetes, obesity, osteoporosis, hyperthyroidism etc.), and metabolic diseases.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Diabetes: Comorbidities, Therapeutics and Insights (Deadline: 30 September 2024)
- Intracellular Biochemical Mechanisms Critical to the Control of Insulin Secretion (Deadline: 30 September 2024)
- Feature Reviews in Adipokines (Deadline: 30 September 2024)
- Lipogenesis and Lipolysis: Insights from Molecular Perspectives (Deadline: 30 September 2024)
- New Diagnostic and Therapeutic Approaches in Diabetic Microvascular Complications, 2nd Edition (Deadline: 31 October 2024)
- Diabetes and Complications of Diabetes: Pathophysiology, Mechanisms, and Therapies (Deadline: 31 October 2024)
- Relationship between Insulin Resistance/Hyperinsulinemia and the Development of Atherosclerosis/Arteriosclerosis as the Cause of Cardiovascular Diseases (Deadline: 31 October 2024)
- Recent Advances in Endocrine Disease and Atherosclerosis (Deadline: 31 October 2024)
- Advanced Research in Metabolic Syndrome (Deadline: 31 October 2024)
- Gut Microbiota and Regulation of Metabolism (Deadline: 31 October 2024)
- Molecular Mechanisms of Steroid Hormone Action—2nd Edition (Deadline: 30 November 2024)
- New Perspectives on Chronic Kidney Disease (Deadline: 30 November 2024)
- Diabetes: Pathogenesis, Therapeutics and Outcomes (Deadline: 30 November 2024)
- Advances in Fatty Acid Metabolism as the Markers of Civilization Diseases 2.0 (Deadline: 30 November 2024)
- Amino Acid Metabolism and Its Role in Cancer Pathogenesis and Treatment (Deadline: 30 November 2024)
- Novel Insights into Liver Metabolism (Deadline: 30 November 2024)
- Diabetic Nephropathy and Diabetic Atherosclerosis (Deadline: 31 December 2024)
- Biomarkers in Metabolic Disorders, Obesity and Type 2 Diabetes Mellitus (Deadline: 31 December 2024)
- Molecular Research on Osteoarthritis and Osteoporosis (Deadline: 31 December 2024)
- Advanced Research on Skeletal Muscle Metabolism (Deadline: 31 January 2025)
- Advanced Research in Diabetic Kidney Disease (Deadline: 31 January 2025)
- Role of miRNAs in Cardiovascular and Metabolic Disorders (Deadline: 31 January 2025)
- The Role of Telomere and Telomerase in Human Disease (Deadline: 31 January 2025)
- Advances in Polycystic Ovary Syndrome Research: From Molecular Mechanisms to Therapeutic Strategies—2nd Edition (Deadline: 31 January 2025)
- Molecular Research in Obesity, 2nd Edition (Deadline: 31 January 2025)
- Feature Reviews in Cell Death (Deadline: 28 February 2025)
- Fatty Liver Disease: From Mechanisms to Therapeutic Approaches (Deadline: 28 February 2025)
- State-of-the-Art Endocrinology and Metabolism Research in Poland (Volume II) (Deadline: 28 February 2025)
- Molecular and Cellular Research in Diabetes and Metabolic Diseases (Deadline: 28 February 2025)
- Peripheral Artery Disease and Diabetic Foot Ulcer: From Bench to Clinic (2nd Edition) (Deadline: 28 February 2025)
- Epigenetics and Metabolic Disorders (Deadline: 28 February 2025)
- Metabolic Construction of Gut Microbes (Deadline: 31 March 2025)
- Connections between Diabetes Mellitus, Other Metabolic and Endocrine Dysfunctions and Cardiovascular Pathologies (Deadline: 31 March 2025)
Topical Collection
Following topical collection within this section is currently open for submissions: